The Gut Microbiome Drives Endogenous T Cell Activation Following CAR-T Cell Therapy
{{output}}
Chimeric antigen receptor (CAR)-T cell therapy has become a promising clinical approach against hematological malignancies, but patients receiving CAR-T cell therapy still presented inconsistent clinical outcomes and are complicated by incomplete tumor eradica... ...
